MATRIX Clinical Research Study

Call 1-866-447-4848
For additional details about
the MATRIX clinical research
study for the treatment of
chronic diabetic foot ulcers

About Excellarate™

What is Excellarate?

Excellarate (also known as GAM501) is an investigational medication that is designed to stimulate wound healing.

How is Excellarate used?

Excellarate is a topical gel that is applied once or twice to the wound over the course of the MATRIX clinical research study.

How does Excellarate work?

The Excellarate topical gel is designed to provide localized and sustained cellular release of a specific growth factor that stimulates a variety of wound healing processes. The Gene Activated Matrix (GAM) technology provides sustained delivery of the growth factor directly at the wound site.

Can anyone be treated with Excellarate?

Excellarate is an investigational medication that is being tested in the MATRIX clinical research study. In order to participate in the MATRIX study, patients must meet the study eligibility criteria that are set by the study protocol reviewed by the FDA.

To find out more about participating in the MATRIX clinical research study, call 1-866-447-4848, or click here.